agilon health inc. Quarterly Income Statement
NYSE: AGLHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
agilon health inc. revenue and earnings
In the quarter ended Jun 30, 2026, agilon health inc. generated $1.49 billion in revenue, up 7.2% from the same quarter a year earlier. Net income was $18.0 million, for a net margin of 1.2% versus a median of -7.5% in the prior 5 quarters. Operating margin was 0.8%.
Diluted earnings per share came in at $1.04.
Summary generated from market data by MetaCap's automated system. Methodology
agilon health inc. income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.49B | 1.42B | 1.57B | 1.44B | 1.39B | 1.53B | 1.52B | 1.45B | 1.48B | 1.60B | 1.06B | 1.14B |
| Revenue growth (YoY) | +7.15% | -7.33% | +3.09% | -1.08% | -5.92% | -4.46% | +44.16% | +27.63% | +38.69% | +52.17% | +185.59% | +63.61% |
| Operating Income | 11.77M | 4.00M | -193.82M | -131.27M | -116.03M | -22.11M | -108.10M | -133.51M | -43.34M | -7.18M | -164.30M | -39.29M |
| Interest Expense | 1.61M | 1.81M | 1.72M | 1.84M | 1.57M | 1.51M | 1.57M | 1.62M | 1.70M | 1.28M | 1.89M | 1.65M |
| Other Income (Expense) | 15.02M | 16.02M | 41.03M | 9.44M | 7.88M | 9.26M | 7.70M | 16.06M | 4.84M | 5.89M | 7.44M | 5.42M |
| Pretax Income | 17.58M | 29.94M | -187.56M | -110.54M | -104.31M | -1.69M | -104.67M | -117.02M | -30.25M | 3.11M | -166.87M | -20.83M |
| Income Tax | -375.00K | 28.00K | 1.32M | -331.00K | 62.00K | 196.00K | 1.76M | -590.00K | 417.00K | -133.00K | 267.00K | 1.21M |
| Net Income | 17.96M | 48.92M | -188.88M | -110.21M | -104.37M | 12.11M | -105.79M | -117.61M | -30.68M | -6.06M | -230.43M | -31.44M |
| Net Income growth (YoY) | — | +303.86% | — | — | — | — | — | — | — | -137.85% | — | — |
| EPS (Basic) | 1.07 | 2.95 | 5.71 | -0.27 | -6.31 | 0.73 | -0.26 | -0.29 | -0.07 | 0.01 | -0.40 | -0.06 |
| EPS (Diluted) | 1.04 | 2.94 | 5.71 | -0.27 | -6.31 | 0.73 | -0.26 | -0.29 | -0.07 | 0.01 | -0.40 | -0.06 |
| Shares Outstanding (Basic) | 16.70M | 16.60M | — | 414.46M | 16.55M | 16.52M | — | 411.59M | 411.27M | 408.94M | — | 405.79M |
| Shares Outstanding (Diluted) | 17.21M | 16.66M | — | 414.46M | 16.55M | 16.52M | — | 411.59M | 411.27M | 408.94M | — | 405.79M |
| EBITDA | 18.63M | 10.78M | -186.86M | -123.84M | -108.71M | -15.23M | -101.61M | -127.29M | -37.44M | -1.33M | -159.15M | -33.98M |
| Operating Margin | 79.00% | 28.00% | -12.35% | -9.15% | -8.32% | -144.00% | -7.10% | -9.20% | -2.92% | -45.00% | -15.56% | -3.46% |
| Net Margin | 120.00% | 3.44% | -12.03% | -7.68% | -7.48% | 79.00% | -6.95% | -8.11% | -2.07% | -38.00% | -21.82% | -2.77% |
This table shows 12 quarterly periods of agilon health inc.'s income statement, from Q2 2026 back to Q3 2023, across 15 line items including revenue, operating expenses, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow AGL's reporting calendar. What is a income statement?